X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (143) 143
index medicus (133) 133
nt-pro-bnp (128) 128
male (113) 113
female (108) 108
natriuretic peptide, brain - blood (97) 97
peptide fragments - blood (84) 84
nt-pro bnp (76) 76
biomarkers - blood (74) 74
middle aged (73) 73
cardiac & cardiovascular systems (72) 72
aged (70) 70
natriuretic peptides (66) 66
brain natriuretic peptide (64) 64
heart failure (64) 64
prognosis (55) 55
mortality (47) 47
heart-failure (42) 42
adult (41) 41
bnp (40) 40
diagnosis (38) 38
risk factors (36) 36
disease (34) 34
echocardiography (30) 30
cardiovascular diseases (29) 29
cardiovascular (27) 27
predictive value of tests (27) 27
aged, 80 and over (25) 25
analysis (25) 25
biomarkers (25) 25
care and treatment (25) 25
nt pro-bnp (25) 25
heart failure - blood (24) 24
prospective studies (24) 24
dysfunction (23) 23
heart failure - diagnosis (23) 23
medicine & public health (23) 23
cardiology (21) 21
follow-up studies (21) 21
natriuretic peptide (21) 21
child (20) 20
medicine, general & internal (20) 20
treatment outcome (20) 20
cardiovascular disease (19) 19
adolescent (18) 18
pediatrics (18) 18
peptides (18) 18
children (17) 17
prognostic value (17) 17
roc curve (17) 17
hypertension (16) 16
left-ventricular dysfunction (16) 16
myocardial-infarction (16) 16
risk (16) 16
sensitivity and specificity (16) 16
c-reactive protein (15) 15
cardiac patients (15) 15
diabetes (15) 15
heart failure - physiopathology (15) 15
research (15) 15
risk stratification (15) 15
diastolic dysfunction (14) 14
hormones, hormone substitutes, and hormone antagonists (14) 14
internal medicine (14) 14
medicine (14) 14
medicine, research & experimental (14) 14
myocardial infarction - blood (14) 14
nt-probnp (14) 14
young adult (14) 14
association (13) 13
cardiovascular system (13) 13
chronic heart-failure (13) 13
time factors (13) 13
biological markers (12) 12
biomarker (12) 12
case-control studies (12) 12
cross-sectional studies (12) 12
endocrinology & metabolism (12) 12
heart attacks (12) 12
marker (12) 12
risk assessment (12) 12
troponin (12) 12
acute myocardial-infarction (11) 11
animals (11) 11
biomarkers - metabolism (11) 11
cardiology and cardiovascular medicine (11) 11
child, preschool (11) 11
congestive-heart-failure (11) 11
electrocardiography (11) 11
health aspects (11) 11
heart (11) 11
medical laboratory technology (11) 11
medical research (11) 11
medicine, experimental (11) 11
nt pro bnp (11) 11
peptide fragments - metabolism (11) 11
troponin t - blood (11) 11
anthracycline-induced cardiotoxicity (10) 10
b-type natriuretic peptide (10) 10
blood pressure (10) 10
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (253) 253
Chinese (5) 5
Spanish (5) 5
French (4) 4
Japanese (4) 4
Korean (4) 4
German (3) 3
Russian (3) 3
Turkish (3) 3
Persian (2) 2
Portuguese (2) 2
Czech (1) 1
Italian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e96736
Cardiotoxicity is a dose-limiting side-effect of cancer chemotherapeutics such as anthracyclines. The drug-induced cardiac toxicity is currently monitored with... 
CARDIAC-FUNCTION | CHRONIC HEART-FAILURE | BRAIN NATRIURETIC PEPTIDE | NT-PRO-BNP | DOXORUBICIN TREATMENT | BIOCHEMICAL MARKERS | MULTIDISCIPLINARY SCIENCES | BREAST-CANCER PATIENTS | ANTHRACYCLINE-INDUCED CARDIOTOXICITY | DYSFUNCTION | OF-THE-LITERATURE | Anthracyclines - adverse effects | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Young Adult | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Registries | Ventricular Function, Left - physiology | Heart Failure - diagnosis | Child | Heart Failure - etiology | Natriuretic Peptide, Brain - blood | Proportional Hazards Models | Neoplasms - mortality | Neoplasms - drug therapy | Gated Blood-Pool Imaging | Adolescent | Aged | Anthracyclines - therapeutic use | Anthracyclines | Chemotherapy | Analysis | Natriuretic peptides | Cancer | Heart | Nuclear medicine | Transplants & implants | Peptides | Toxicity | Cardiomyopathy | Radioisotopes | Population studies | Congestive heart failure | Medical diagnosis | Cancer therapies | Physiology | Bioindicators | Drug dosages | Monitoring | Heart failure | Brain natriuretic peptide | Echocardiography | Cut-off | Mortality | Breast cancer | Patients | Equilibrium | Studies | Side effects | Hospitals | Anthracycline | Biomarkers | Death | Ventricle
Journal Article
Congenital Heart Disease, ISSN 1747-079X, 07/2018, Volume 13, Issue 4, pp. 499 - 505
Aim To evaluate predictors of morbidity and mortality in pediatric patients with pulmonary hypertension (PH), laboratory and echocardiographic measures of PH... 
mortality | morbidity | pCO2 | NT‐pro BNP | pulmonary hypertension | NT-pro BNP | pCO | SURVIVAL | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | BRAIN NATRIURETIC PEPTIDE | MANAGEMENT | HEART-FAILURE | CARE | PRESSURE | BIRTH-WEIGHT INFANTS | OUTCOMES | Genetic disorders | Analysis | Mortality | African Americans | Infants | Congenital heart disease | Children | Heart diseases | Health aspects | Pulmonary hypertension
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 01/2020, Volume 298, pp. 93 - 97
Elevated levels of B-type natriuretic peptide (BNP) and NT-pro-BNP can predict an increased risk of cardiovascular events and ischemic stroke. The limited... 
NT-pro-BNP | Secondary prevention | Stroke | Biomarker | Transient ischemic attack | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | BRAIN NATRIURETIC PEPTIDE | SUBTYPES | ATHEROSCLEROSIS | ATRIAL-FIBRILLATION | PLASMA-LEVELS | SEVERITY
Journal Article
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 11/2017, Volume 21, Issue 11, pp. 2677 - 2684
This study investigated roles of serum ST2, IL‐33 and BNP in predicting major adverse cardiovascular events (MACEs) in acute myocardial infarction (AMI) after... 
ST2 | IL‐33 | Percutaneous coronary intervention | Major adverse cardiovascular events | Acute myocardial infarction | BNP | IL-33 | MEDICINE, RESEARCH & EXPERIMENTAL | BRAIN NATRIURETIC PEPTIDE | PROGNOSIS | HEART-FAILURE | CARDIAC EVENTS | SERUM-SOLUBLE ST2 | CELL BIOLOGY | NT-PRO BNP | EXPRESSION | SEVERITY | RECEPTOR FAMILY-MEMBER | ARTERY-DISEASE | Myocardial Infarction - blood | Predictive Value of Tests | Myocardial Infarction - mortality | Prognosis | Area Under Curve | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Coronary Vessels - metabolism | Female | Interleukin-1 Receptor-Like 1 Protein - genetics | Myocardial Infarction - etiology | Natriuretic Peptide, Brain - blood | Myocardial Infarction - diagnosis | Severity of Illness Index | Coronary Vessels - pathology | Gene Expression | Natriuretic Peptide, Brain - genetics | Kaplan-Meier Estimate | Biomarkers - blood | Acute Coronary Syndrome - blood | Interleukin-33 - blood | Interleukin-33 - genetics | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - etiology | Interleukin-1 Receptor-Like 1 Protein - blood | ROC Curve | Aged | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Medical research | Analysis | Cardiac patients | Medicine, Experimental | Enzyme-linked immunosorbent assay | Heart attack | Original
Journal Article
Journal Article
Journal Article
Journal Article
Clinica Chimica Acta, ISSN 0009-8981, 05/2018, Volume 480, pp. 26 - 33
Cardiogenic pulmonary edema (CPE) is a life-threatening emergency necessitating aggressive management. We conducted this study to test the hypothesis that a... 
Heart failure | NT-pro-BNP | Cardiogenic pulmonary edema | Scoring system | DIAGNOSIS | MANAGEMENT | GUIDELINES | EMERGENCY-DEPARTMENT | TASK-FORCE | DISEASE | UPDATE | IN-HOSPITAL MORTALITY | MEDICAL LABORATORY TECHNOLOGY | ELDERLY-PATIENTS | ASSOCIATION
Journal Article